Search Results for "Skin"
Search again or select article below to purchase. Single article price: $45. Order 3 or more at one time and receive a 10% discount.
Sort by relevance | Sort by date
Searched for Skin. Results 241 to 250 of 438 total matches.

Epoprostenol for Primary Pulmonary Hypertension

   
The Medical Letter on Drugs and Therapeutics • Feb 16, 1996  (Issue 968)
under the skin. The initial dosage recommended by the manufacturer is 2 ng/kg/min with subsequent ...
Epoprostenol sodium (Flolan - Glaxo Wellcome), also known as prostacyclin, has been approved by the US Food and Drug Administration for continuous intravenous treatment of primary pulmonary hypertension.
Med Lett Drugs Ther. 1996 Feb 16;38(968):14-5 |  Show IntroductionHide Introduction

Temozolomide for Refractory Anaplastic Astrocytoma

   
The Medical Letter on Drugs and Therapeutics • Dec 17, 1999  (Issue 1068)
or otherwise damage the capsules and to avoid inhalation of the drug or contact with skin or mucous membranes ...
Temozolomide has received accelerated approval from the FDA for oral treatment of adults with anaplastic astrocytoma that has relapsed after treatment with a nitrosourea (lomustine or carmustine) and procarbazine.
Med Lett Drugs Ther. 1999 Dec 17;41(1068):123-4 |  Show IntroductionHide Introduction

What about Niacin?

   
The Medical Letter on Drugs and Therapeutics • Nov 28, 2011  (Issue 1378)
— Niacin can cause skin flushing, pruritus, gastrointestinal distress, blurred vision, fatigue, glucose ...
The results of the AIM-HIGH trial conducted by the US National Heart, Lung and Blood Institute (NHLBI) were recently published. The goal of the trial was to test whether addition of niacin to intensive statin therapy would further reduce the risk of cardiovascular disease. The trial was stopped prematurely after an average follow-up of 3 years because niacin therapy had not shown any clinical benefit.
Med Lett Drugs Ther. 2011 Nov 28;53(1378):93-4 |  Show IntroductionHide Introduction

In Brief: An Asenapine Patch (Secuado) for Schizophrenia

   
The Medical Letter on Drugs and Therapeutics • Jan 11, 2021  (Issue 1615)
to clean, dry, intact skin on the upper arm, upper back, abdomen, or hip. The new patch should be applied ...
A transdermal formulation of the second-generation (atypical) antipsychotic asenapine (Secuado – Noven) has been approved by the FDA for once-daily treatment of schizophrenia in adults. Asenapine is the first antipsychotic to become available in a transdermal formulation in the US. A twice-daily sublingual tablet formulation of asenapine (Saphris) has been available since 2009.
Med Lett Drugs Ther. 2021 Jan 11;63(1615):7-8 |  Show IntroductionHide Introduction

Ashwagandha Supplements

   
The Medical Letter on Drugs and Therapeutics • Mar 08, 2021  (Issue 1619)
lines.8 ADVERSE EFFECTS — Severe diarrhea, skin burning and discoloration, and sedation can occur ...
Ashwagandha is an herb extracted from the roots of an evergreen shrub (Withania somnifera) found in India that has been used as a "tonic" for centuries. No specific constituent has been identified as an active ingredient. Herbal supplements containing ashwagandha, which is also known as winter cherry and Indian ginseng, are widely promoted now in the US for treatment of pain, anxiety, stress, fatigue, sleep disturbances, cognitive decline, diabetes, arthritis, male infertility, and various cancers.
Med Lett Drugs Ther. 2021 Mar 8;63(1619):39-40 |  Show IntroductionHide Introduction

Two New Oral Testosterone Products for Hypogonadism

   
The Medical Letter on Drugs and Therapeutics • Oct 31, 2022  (Issue 1662)
of the drug to women and children, and skin and nasal irritation have been reported with these formulations ...
The FDA has approved two new oral formulations of testosterone undecanoate — Kyzatrex (Marius) and Tlando (Antares) — for treatment of males with a deficiency of endogenous testosterone due to conditions such as Klinefelter syndrome, orchiectomy, toxic damage from chemotherapy or alcohol, or pituitary-hypothalamic injury caused by tumors, trauma, or radiation. Jatenzo, another oral testosterone undecanoate formulation, was approved for the same indication in 2019. No testosterone products are approved for treatment of low testosterone levels due solely to...
Med Lett Drugs Ther. 2022 Oct 31;64(1662):172-4 |  Show IntroductionHide Introduction

Antimicrobial Prophylaxis for Surgery

   
The Medical Letter on Drugs and Therapeutics • May 23, 2016  (Issue 1495)
infection, inflammation, and skin erosion.10 GASTROINTESTINAL SURGERY — Prophylaxis is not recommended ...
Antimicrobial prophylaxis can decrease the incidence of postoperative surgical site infection after some procedures. Since the last Medical Letter article on this subject, consensus guidelines have been published. Recommendations for prophylaxis in specific surgical procedures are listed in Table 1.
Med Lett Drugs Ther. 2016 May 23;58(1495):63-8 |  Show IntroductionHide Introduction

Trimetrexate

   
The Medical Letter on Drugs and Therapeutics • Jan 27, 1989  (Issue 784)
, the main toxic effects were granulocytopenia, thrombocytopenia, mucositis and skin rash (JA Stewart, Semin ...
Trimetrexate glucuronate (Parke-Davis), an investigational drug, is now available in the USA from the National Institute of Allergy and Infectious Diseases (NIAID) for treatment of selected AIDS patients with Pneumocystis carinii pneumonia (PCP). For this indication, trimetrexate is always used concurrently with leucovorin (Wellcovorin; and others).
Med Lett Drugs Ther. 1989 Jan 27;31(784):5-6 |  Show IntroductionHide Introduction

Etidronate for Postmenopausal Osteoporosis

   
The Medical Letter on Drugs and Therapeutics • Dec 14, 1990  (Issue 833)
. In patients with Paget’s disease, allergic skin rashes have been reported. DOSAGE AND COST — The dosage ...
Etidronate (e ti droe' nate) disodium (Didronel - Norwich Eaton), an oral bisphosphonate available for many years for treatment of Paget's disease (Medical Letter, 20:78, 1978), recently has also been used for treatment of postmenopausal osteoporosis.
Med Lett Drugs Ther. 1990 Dec 14;32(833):111-4 |  Show IntroductionHide Introduction

Clonidine for Treatment of Attention-Deficit/Hyperactivity Disorder

   
The Medical Letter on Drugs and Therapeutics • Dec 06, 1996  (Issue 989)
, also in 10 children with ADHD, found that either oral clonidine or a clonidine skin patch ...
Clonidine, an Alpha2-selective adrenergic agonist marketed in the USA only for treatment of hypertension, has also been used in recent years to treat children with attention-deficit/hyperactivity disorder (ADHD).
Med Lett Drugs Ther. 1996 Dec 6;38(989):109-10 |  Show IntroductionHide Introduction